35 results
ARS
2022 FY
PNT
POINT Biopharma Global Inc.
1 May 23
Annual report to shareholders
1:52pm
ability to recruit and enroll suitable patients in our clinical trials; the potential attributes and benefits of our product candidates; our ability … ; the design of the trial; its ability to recruit clinical trial investigators with the appropriate competencies and experience; competing clinical trials
424B5
ao2ebs06qbac0btn5
14 Sep 22
Prospectus supplement for primary offering
4:12pm
424B5
cu526ud7hty8ayv
13 Sep 22
Prospectus supplement for primary offering
5:19pm
424B3
ovtk6bxgwl7oa61o41
11 Jul 22
Prospectus supplement
4:32pm
POS AM
a31 l0wxu1
1 Jul 22
Prospectus update (post-effective amendment)
4:17pm
S-3
1rm0et9zul
1 Jul 22
Shelf registration
4:13pm
424B3
uuvip
13 May 22
Prospectus supplement
8:18am
424B3
gu49j9kisan dmj6f
31 Mar 22
Prospectus supplement
11:42am
POS AM
zgo 9n29k8yyr4axsj
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
424B3
dkr17 9o0plc8w
12 Nov 21
Prospectus supplement
8:41am
424B3
58eb 2ypi6l
13 Aug 21
Prospectus supplement
5:25pm